Fang Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Basal Cell Carcinoma

Monoclonal Antibody

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Joyce Wei, Welby Montalvo-Ortiz, Lola Yu, Amanda Krasco, Kara Olson, Sahar Rizvi, Nathalie Fiaschi, Sandra Coetzee, Fang Wang, Erica Ullman, Hassan Shakil Ahmed, Evan Herlihy, Ken-Wing Lee, Lauren Havel, Terra Potocky, Sarah Ebstein, Davor Frleta, Aditi Patel, Stephen Godin, Sara Hamon, Jurriaan Brouwer-Visser, Travis Gorenc, Douglas MacDonald, Aynur Hermann, Aafia Chaudhry, Andres Sirulnik, William C Olson, John Lin, Gavin Thurston, Israel Lowy, Andrew J Murphy, Eric Smith, Vladimir Jankovic, Matthew A Sleeman, Dimitris Skokos
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models. Science translational medicine 14 (670) (2022)